Exact Mass: 597.3513

Exact Mass Matches: 597.3513

Found 18 metabolites which its exact mass value is equals to given mass value 597.3513, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

5-O-beta-D-Mycaminosyltylonolide

5-O-β-D-Mycaminosyltylonolide

C31H51NO10 (597.3513)

Mycaminosyltylonolide

5-O-beta-D-Mycaminosyltylonolide

C31H51NO10 (597.3513)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007933 - Leucomycins Mycaminosyltylonolide is a potent antibiotic. Mycaminosyltylonolide shows antibacterial activity. Mycaminosyltylonolide inhibits luciferase synthesis[1][2].

(2E,4E,9R)-9-hydroxy-10-[(2R,4R,6S)-6-[(S)-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-methoxymethyl]-4-methoxy-3,3-dimethyloxan-2-yl]deca-2,4-dienoic acid

(2E,4E,9R)-9-hydroxy-10-[(2R,4R,6S)-6-[(S)-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-methoxymethyl]-4-methoxy-3,3-dimethyloxan-2-yl]deca-2,4-dienoic acid

C31H51NO10 (597.3513)

5-O-mycaminosyltylonolide

C31H51NO10 (597.3513)

A macrolide antibiotic that is tylonolide having a beta-D-mycaminosyl residue attached at position 5.

DGCC 21:4;O2

C31H51NO10 (597.3513)

ST 23:1;O5;HexNAc

C31H51NO10 (597.3513)

(9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl)acetic acid

C31H51NO10 (597.3513)

(2e,4e)-10-[(2r,4r,6s)-6-[(s)-{[(2s)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

(2e,4e)-10-[(2r,4r,6s)-6-[(s)-{[(2s)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)

2-[(14e)-9-{[4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO10 (597.3513)

(2e,4e,9s)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

(2e,4e,9s)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)

10-[6-({[1,2-dihydroxy-2-(2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl)ethylidene]amino}(methoxy)methyl)-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)

[(1s,2r,3r,7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3s,4s,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetic acid

[(1s,2r,3r,7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3s,4s,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetic acid

C31H51NO10 (597.3513)

(2e,4e,9r)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

(2e,4e,9r)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)